Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cassava Sciences Inc
SAVACurrent price
2.61 USD
-0.16 USD (-5.78%)
Last closed
2.83 USD
Company
www.cassavasciences.com
ISIN
US14817C1071
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
127 973 936 USD
Yield for 12 month
-89.86 %
1Y
3Y
5Y
10Y
15Y
SAVA
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Address: 6801 N. Capital of Texas Highway, Austin, TX, United States, 78731
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
116.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
-1 800 USD
Current Quarter
–
Last Quarter
–
Current Year
-89 423 000 USD
Last Year
-1 800 USD
Current Quarter
–
Last Quarter
-300 000 USD
Key Figures SAVA
1 year
3 years
5 years
10 years
EBITDA
-143 320 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-45.60 %
PEG Ratio
–
Return On Equity TTM
-10.98 %
Wall Street Target Price
116.00 USD
Revenue TTM
–
Book Value
3.47 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-68 032 000 USD
Earnings per share
-1.38 USD
Diluted Eps TTM
-1.38 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics SAVA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History SAVA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
13.12.2012
Forward Annual Dividend Yield
–
Last Split Factor
1:7
Payout Ratio
–
Last Split Date
10.05.2017
Dividend Date
10.05.2017
Stock Valuation SAVA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
151.52
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-8.26
Price Book MRQ
0.79
Financials SAVA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SAVA
For 52 weeks
2.55 USD
42.20 USD
50 Day MA
20.31 USD
Shares Short Prior Month
18 083 425
200 Day MA
21.56 USD
Short Ratio
1.95
Shares Short
17 161 905
Short Percent
38.06 %
BeatStart